Among the four populations, which were represented with at least 1% cells among Treg (Figure 2D), the most prevalent in both CLL patients and HC was the CD45RA−CD25low+ non-Treg-like population, which lacked expression of other markers, including CXCR5. This evidence concerns the gene CXCR5 and B-cell chronic lymphocytic leukemia.